CAS 1199590-75-4

Gne 220

CAS : 1199590-75-4

Gne 220

Masse moléculaire : 438.52754g/mol

Ref: 54-BISN0270

6-Methyl-12-[4-(4-methylpiperazin-1-yl)phenyl]-4-(1-methylpyrazol-4-yl)-3,5,8,10-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12 -hexaene

CAS : 1199590-75-4

6-Methyl-12-[4-(4-methylpiperazin-1-yl)phenyl]-4-(1-methylpyrazol-4-yl)-3,5,8,10-tetrazatricyclo[7.4.0.0^2,7]trideca-1(9),2,4,6,10,12-hexaene is a synthetic heterocyclic compound, which is developed as part of pharmaceutical research focused on oncology. This compound is synthesized through complex organic chemistry techniques to achieve a unique configuration that interacts with specific biological pathways. Its mode of action involves binding to certain molecular targets within cancer cells, thereby modulating signaling pathways that control cell proliferation, apoptosis, and other critical functions pertinent to tumor growth and metastasis.

Formule : C₂₅H₂₆N₈

Degré de pureté : Min. 95%

Masse moléculaire : 438.5 g/mol

Ref: 3D-ZXB59075

GNE 220

CAS : 1199590-75-4

GNE-220 is a potent and selective inhibitor of MAP4K4 (IC50: 7 nM).

Formule : C₂₅H₂₆N₈

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 438.53

Ref: TM-T11443